Olutasidenib Market Analysis By Application (Acute myeloid leukemia (AML), Other therapeutic areas), by Type (Generic Olutasidenib, Branded Olutasidenib), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and by Region: Global Forecast, 2024 - 2034.
- PUBLISHED ON
- 2024-08-13
- NO OF PAGES
- 310
- CATEGORY
- Healthcare & Life Sciences
Market Overview
The Olutasidenib market is predicted to
develop at a compound annual growth rate (CAGR) of xx from
2024 to 2034, when it is projected to reach USD xx Billion, based on an average
growth pattern. The market is estimated to reach a value of USD xx Billion in
2024.
Â
SOURCE: We Market Research
IDH1-mutant
acute myeloid leukemia (AML) can be treated with the targeted medication
olinusidenib. It prevents development and survival of cancer cells by
inhibiting the mutant IDH1 enzyme. Olutasidenib inhibits this enzyme, which
slows down the growth of cancer cells and, in people carrying this particular
genetic mutation, may result in remission. Primarily, it is employed in cases
where alternative therapies have proven ineffective or incorrect. Oral
administration of the medication is the standard method; however, based on the
patient's condition and response, it may be coupled with other treatments.
Assessing efficacy and controlling possible negative effects require routine
monitoring.
The increasing prevalence of acute myeloid leukemia (AML), improvements in targeted medicines, and a large unmet medical need are driving the global olutasidenib market. Olutasidenib increases market demand by providing AML patients with restricted therapy options by targeting the IDH1 mutation. Its market expansion is further aided by regulatory approvals and successful clinical trial outcomes. Moreover, earlier and more widespread usage of the medication is a result of raised awareness and early identification of IDH1 mutations. Together, these elements support the market for olutasidenib's increasing uptake and growth.
Market Scope
|
Report Attributes |
Description |
|
Market Size in 2024 |
USD xx Billion |
|
Market
Forecast in 2034 |
USD xx Billion |
|
CAGR % 2024-2034 |
xx% |
|
Base
Year |
2023 |
|
Historic Data |
2016-2022 |
|
Forecast
Period |
2024-2034 |
|
Report USP Â |
Production,
Consumption, company share, company heatmap, company production capacity,
growth factors and more |
|
Segments
Covered |
by
Application, by Type, by Distribution Channel and By Region |
|
Regional Scope |
North America,
Europe, APAC, South America and Middle East and Africa |
|
Country
Scope |
U.S.; Canada;
U.K.; Germany; France; Italy; Spain; Benelux; Nordic Countries; Russia;
China; India; Japan; South Korea; Australia; Indonesia; Thailand; Mexico;
Brazil; Argentina; Saudi Arabia; UAE; Egypt; South Africa; Nigeria |
Olutasidenib Industry: Dynamics & Restrains
 
Market opportunity:
We Market
Research: Olutasidenib Dashboard
Our marketing platform offers a comprehensive dashboard that provides clients with valuable insights into market trends over the years. Included below is a sample image of our dashboard, and specific PDF logins will be furnished to grant access to this insightful tool.
Olutasidenib Segmentation
Market- By Application Analysis
By Application, the Olutasidenib Market is Categories into Acute myeloid leukemia (AML) , Other therapeutic areas. The Acute myeloid leukemia (AML) segment accounts for the largest share of around 90% in 2024.
The driver for Acute Myeloid Leukemia (AML)
in the global Olutasidenib market is the rising incidence of AML and the need
for targeted, effective treatments. Advances in understanding AML’s genetic
basis further boost demand for specialized therapies like Olutasidenib.
The
following segments are part of an in-depth analysis of the global Olutasidenib
market:
|
Market
Segments |
 |
|
by Type |
·       Â
Generic Olutasidenib ·       Â
Branded Olutasidenib |
|
by
Distribution Channel |
·       Â
Hospital Pharmacies ·       Â
Retail Pharmacies ·       Â
Online Pharmacies |
Olutasidenib Industry: Regional Analysis
North America Market Forecast
North America dominates the Olutasidenib Market with the highest revenue generating market with share of more than 47%. North America is a leading market for olutasidenib, driven by its advanced healthcare infrastructure and significant investments in research and development. The high prevalence of acute myeloid leukemia (AML) and the extensive number of clinical trials conducted in the U.S. and Canada create a strong demand for innovative treatments. This region's mature healthcare ecosystem and focus on cutting-edge therapies further boost market potential.
Europe Market Statistics
Europe’s market
for Olutasidenib benefits from its robust healthcare systems and substantial
clinical research activities. Countries like Germany, France, and the UK offer
supportive regulatory environments and high cancer incidence rates, enhancing
demand. The region’s investment in cancer research and development, coupled
with improving patient access to novel treatments, creates a favorable
landscape for Olutasidenib, contributing to its growth potential in Europe.
Asia Pacific Market Forecasts
The Asia-Pacific region is experiencing rapid growth in its pharmaceutical sector, driven by increased healthcare investments and a rising cancer burden. Countries such as China and India are expanding their clinical trial networks and healthcare infrastructure, providing significant opportunities for Olutasidenib. The growing patient populations and enhanced research capabilities in these countries support the drug’s market expansion and potential for adoption.
Key Market Players
·       Â
AbbVie Inc.Â
1.    Â
Global
Olutasidenib Market Introduction and Market Overview
1.1.   Objectives of the Study
1.2.   Global Olutasidenib Market Scope
and Market Estimation
1.2.1. Global Olutasidenib Overall
Market Size, Revenue (US$ Mn), Market CAGR (%), Market forecast (2023 - 2034)
1.2.2. Global Olutasidenib Market
Revenue Share (%) and Growth Rate (Y-o-Y) from 2019 - 2034
1.3.   Market Segmentation
1.3.1. Application of Global Olutasidenib
Market
1.3.2. Type of Global Olutasidenib
Market
1.3.3. Distribution Channel of Global Olutasidenib
Market
1.3.4. Region of Global Olutasidenib
Market
2.    Â
Executive Summary
2.1.   Market Dynamics
2.1.1. Drivers
2.1.2. Limitations
2.1.3. Opportunities
2.1.4. Impact Analysis of Drivers and
Restraints
2.2.   Pricing Trends Analysis &
Average Selling Prices (ASPs)
2.3.   Key Mergers & Acquisitions,
Expansions, JVs, Funding / VCs, etc.
2.4.   Porter’s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitutes
2.4.4. Threat of New Entrants
2.4.5. Competitive Rivalry
2.5.     Market Investment Opportunity
Analysis (Top Investment Pockets), By Segments & By Region
3.    Â
Global Olutasidenib Market Estimates & Historical Trend Analysis (2019 -
2023)
4.    Â
Global Olutasidenib Market Estimates & Forecast Trend Analysis, by
Application
4.1.   Global Olutasidenib Market
Revenue (US$ Mn) Estimates and Forecasts, by Application, 2019 to 2034
4.1.1. Acute myeloid leukemia (AML)
4.1.2. Other therapeutic areas
5.    Â
Global Olutasidenib Market Estimates & Forecast Trend Analysis, by
Type
5.1.   Global Olutasidenib Market
Revenue (US$ Mn) Estimates and Forecasts, by Type, 2019 to 2034
5.1.1. Generic Olutasidenib
5.1.2. Branded Olutasidenib
6.    Â
Global Olutasidenib Market Estimates & Forecast Trend Analysis, by
Distribution Channel
6.1.   Global Olutasidenib Market
Revenue (US$ Mn) Estimates and Forecasts, by Distribution Channel,
2019 to 2034
6.1.1. Hospital Pharmacies
6.1.2. Retail Pharmacies
6.1.3. Online Pharmacies
7.    Â
Global Olutasidenib Market Estimates & Forecast Trend Analysis,
by region
7.1.   Global Olutasidenib Market
Revenue (US$ Mn) Estimates and Forecasts, by region, 2019 to 2034
7.1.1. North America
7.1.2. Europe
7.1.3. Asia Pacific
7.1.4. Middle East & Africa
7.1.5. South America
8.    Â
North
America Olutasidenib Market: Estimates & Forecast Trend Analysis
8.1.  Â
North
America Olutasidenib Market Assessments & Key Findings
8.1.1. North America Olutasidenib
Market Introduction
8.1.2. North America Olutasidenib
Market Size Estimates and Forecast (US$ Million) (2019 – 2034)
8.1.2.1.  By TYPE
8.1.2.2.  By Application
8.1.2.3.  By End-user
8.1.2.4.  By Country
8.1.2.4.1.    The U.S.
8.1.2.4.2.    Canada
8.1.2.4.3.    Mexico
9.    Â
Europe
Olutasidenib Market: Estimates & Forecast Trend Analysis
9.1.   Europe Olutasidenib Market
Assessments & Key Findings
9.1.1. Europe Olutasidenib Market
Introduction
9.1.2. Europe Olutasidenib Market Size
Estimates and Forecast (US$ Million) (2019 – 2034)
9.1.2.1.  By Application
9.1.2.2.  By Type
9.1.2.3.  By Distribution
Channel
9.1.2.4.      Â
By
Country
9.1.2.4.1.    Germany
9.1.2.4.2.    U.K.
9.1.2.4.3.    France
9.1.2.4.4.    Italy
9.1.2.4.5.    Spain
9.1.2.4.6.    Russia
9.1.2.4.7.    Rest of Europe
10. Asia Pacific Olutasidenib
Market: Estimates & Forecast Trend
Analysis
10.1. Asia Pacific Market Assessments
& Key Findings
10.1.1.  Asia Pacific Olutasidenib Market
Introduction
10.1.2.  Asia Pacific Olutasidenib Market
Size Estimates and Forecast (US$ Million) (2019 – 2034)
10.1.2.1.   By Application
10.1.2.2.   By Type
10.1.2.3.   By Distribution
Channel
10.1.2.4.   By Country
10.1.2.4.1. China
10.1.2.4.2. Japan
10.1.2.4.3. India
10.1.2.4.4. Australia
10.1.2.4.5. South Korea
10.1.2.4.6. ASEAN
10.1.2.4.7. Rest of Asia Pacific
11. Middle East & Africa Olutasidenib
Market: Estimates & Forecast Trend
Analysis
11.1. Middle East & Africa Market
Assessments & Key Findings
11.1.1.  Middle
East & Africa Olutasidenib
Market Introduction
11.1.2.  Middle
East & Africa Olutasidenib
Market Size Estimates and Forecast (US$ Million) (2019 – 2034)
11.1.2.1.   By Application
11.1.2.2.   By Type
11.1.2.3.   By Distribution
Channel
11.1.2.4.   By Country
11.1.2.4.1. U.A.E.
11.1.2.4.2. Saudi Arabia
11.1.2.4.3. Egypt
11.1.2.4.4. South Africa
11.1.2.4.5. Rest of Middle East & Africa
12. South America
Olutasidenib Market: Estimates &
Forecast Trend Analysis
12.1. South America Market Assessments
& Key Findings
12.1.1.  South America Olutasidenib
Market Introduction
12.1.2.  South America Olutasidenib
Market Size Estimates and Forecast (US$ Million) (2019 – 2034)
12.1.2.1.   By Application
12.1.2.2.   By Type
12.1.2.3.   By Distribution
Channel
12.1.2.4.   By Country
12.1.2.4.1. Brazil
12.1.2.4.2. Argentina
12.1.2.4.3. Colombia
12.1.2.4.4. Rest of South America
13. Competition Landscape
13.1. Global Olutasidenib Market
Competition Matrix & Benchmarking, by Leading Players / Innovators /
Emerging Players / New Entrants
13.2. Global Olutasidenib Market
Competition White Space Analysis, By End-user
13.3. Global Olutasidenib Market
Competition Heat Map Analysis, By End-user
13.4. Global Olutasidenib Market
Concentration & Company Market Shares (%) Analysis, 2022
14. Company Profiles
14.1.                   Â
AbbVie Inc.
14.1.1.  Company Overview & Key Stats
14.1.2.  Financial Performance & KPIs
14.1.3.  Product Portfolio
14.1.4.  Business Strategy & Recent
Developments
15. Research
Methodology
15.1. External Transportations /
Databases
15.2. Internal Proprietary Database
15.3. Primary Research
15.4. Secondary Research
15.5. Assumptions
15.6. Limitations
15.7. Report FAQs
16. Research Findings & ConclusionÂ
Quality Assurance Process
- We Market Research’s Quality Assurance program strives to deliver superior value to our clients.
We Market Research senior executive is assigned to each consulting engagement and works closely with the project team to deliver as per the clients expectations.
Market Research Process
We Market Research monitors 3 important attributes during the QA process- Cost, Schedule & Quality. We believe them as a critical benchmark in achieving a project’s success.
To mitigate risks that can impact project success, we deploy the follow project delivery best practices:
- Project kickoff meeting with client
- Conduct frequent client communications
- Form project steering committee
- Assign a senior SR executive as QA Executive
- Conduct internal editorial & quality reviews of project deliverables
- Certify project staff in SR methodologies & standards
- Monitor client satisfaction
- Monitor realized value post-project
Case Study- Automotive Sector
One of the key manufacturers of automotive had plans to invest in electric utility vehicles. The electric cars and associated markets being a of evolving nature, the automotive client approached We Market Research for a detailed insight on the market forecasts. The client specifically asked for competitive analysis, regulatory framework, regional prospects studied under the influence of drivers, challenges, opportunities, and pricing in terms of revenue and sales (million units).
Solution
The overall study was executed in three stages, intending to help the client meet its objective of precisely understanding the entire market before deciding on an investment. At first, secondary research was conducted considering political, economic, social, and technological parameters to get a gist of the various aspects of the market. This stage of the study concluded with the derivation of drivers, opportunities, and challenges. It also laid substantial emphasis on understanding and collecting data not only on a global scale but also on the regional and country levels. Data Extraction through Primary Research
The second stage involved primary research in which several market players and automotive parts suppliers were contacted to study their viewpoint concerning the development of their market and production capacity, clientele, and product line. This stage concluded in a brief understanding of the competitive ecosystem and also glanced through the strategies and pricing of the companies profiled.
Market Estimates and Forecast
In the final stage of the study, market forecasts for the electric utility were derived using multiple market engineering approaches. This data helped the client to get an overview of the market and accelerate the process of investment.
Case Study- ICT Sector
Business process outsourcing, being one of the lucrative markets from both supply- and demand- side, has appealed to various companies. One of the prominent corporations based out of Japan approached us with their requirements regarding the scope of the procurement outsourcing market for around 50 countries. Additionally, the client also sought key players operating in the market and their revenue breakdown in terms of region and application.
Business Solution
An exhaustive market study was conducted based on primary and secondary research that involved factors such as labor costs in various countries, skilled and technical labors, manufacturing scenario, and their respective contributions in the global GDP. A comparative study of the market was conducted from both supply- and demand side, with the supply-side comprising of notable companies, such as GEP, Accenture, and others, that provide these services. On the other hand, large manufacturing companies from them demand-side were considered that opt for these services.
Conclusion
The report aided the client in understanding the market trends, including country-level business scenarios, consumer behavior, and trends in 50 countries. The report also provided financial insights of crucial players and detailed market estimations and forecasts till 2033.
Frequently Asked Questions
What is the market size of Olutasidenib Market in 2024?
Olutasidenib Market was valued at USD xx Billion in 2024.
What is the growth rate for the Olutasidenib Market?
Olutasidenib Market size will increase at approximate CAGR of xx% during the forecasted period.
Which are the top companies operating within the market?
Major companies operating within the Olutasidenib Market is AbbVie Inc.
Which region dominates the Olutasidenib Market?
North America dominates the market with an active share of 47%.
}})
Select a license type that suits your business needs
US $3499
Only Three Thousand Four Hundred Ninety Nine US dollar
- 1 User access
- 15% Additional Free Customization
- Free Unlimited post-sale support
- 100% Service Guarantee until achievement of ROI
US $4499
Only Four Thousand Four Hundred Ninety Nine US dollar
- 5 Users access
- 25% Additional Free Customization
- Access Report summaries for Free
- Guaranteed service
- Dedicated Account Manager
- Discount of 20% on next purchase
- Get personalized market brief from Lead Author
- Printing of Report permitted
- Discount of 20% on next purchase
- 100% Service Guarantee until achievement of ROI
US $5499
Only Five Thousand Four Hundred Ninety Nine US dollar
- Unlimited User Access
- 30% Additional Free Customization
- Exclusive Previews to latest or upcoming reports
- Discount of 30% on next purchase
- 100% Service Guarantee until achievement of ROI